FDA Pulls Painkiller Due to Safety Risks
December 13, 2010 by admin
Filed under News Stories
December 13th, 2010
Fox News
The maker of the painkiller Darvon is pulling the drug off the market under pressure from public health officials who say it causes dangerous heart rhythms.
The Food and Drug Administration says the drugmaker Xanodyne will halt marketing of Darvon and related brand Darvocet. The FDA has also called on generic drugmakers to stop marketing low-cost versions of the drug.
The FDA action puts the U.S. in line with Britain, which banned Darvon several years ago due to suicides and accidental overdoses.
Darvon, first approved in the 1950s, is an opioid used to treat mild to moderate pain.
Dr. Manny Alvarez, senior managing health editor of FoxNews.com, said Darvon is still prescribed for chronic pain, mostly in generic form, although not very often.
“These types of drugs are in a class of their own,” Alvarez said. “They are old and there are certainly newer drugs that are far more sophisticated and even safer.”
The consumer watchdog group Public Citizen had petitioned the FDA to ban the drug, saying its benefits didn’t justify a risk that added up to several hundred deaths a year.
Click here for the full report from Fox News
FDA Pulls Painkiller Darvon Over Safety Risks
November 22, 2010 by admin
Filed under News Stories
November 22nd, 2010
AOL News
By: Matthew Perrone
The maker of the painkiller Darvon is pulling the drug off the market under pressure from public health officials who say it causes dangerous heart rhythms.
The Food and Drug Administration says the drugmaker Xanodyne will halt marketing of Darvon and related brand Darvocet. The FDA has also called on generic drugmakers to stop marketing low-cost versions of the drug.
The FDA action puts the U.S. in line with Britain, which banned Darvon several years ago due to suicides and accidental overdoses.
Darvon, first approved in the 1950s, is an opioid used to treat mild to moderate pain.
The consumer watchdog group Public Citizen had petitioned the FDA to ban the drug, saying its benefits didn’t justify a risk that added up to several hundred deaths a year.
